Author
Anti-abortion groups say Supreme Court’s mifepristone ruling won’t deter them
An attorney for the plaintiffs said the ruling was disappointing, but that they will continue to “advocate for women’s health.”
Hundreds protest outside the U.S. Supreme Court to keep abortion medication accessible
The justices heard oral arguments in U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine Tuesday, their first major reproductive rights case since overturning Roe v. Wade almost two years ago.
Telehealth abortions on the rise since Dobbs, new report shows
Before Dobbs, about 4% of total recorded abortions were via telehealth abortion; that rose to 16%, as of September 2023.
Fear and confusion over abortion access persists as SCOTUS takes its first post-Dobbs case
Experts have said that a U.S. Supreme Court ruling on the use of mifepristone, a key abortion medication, could have implications for drug approval by the U.S. Food and Drug Administration.
Abortion-rights victories cement 2024 playbook while opponents scramble for new strategy
Anti-abortion leaders woke up Wednesday to the sobering reality that abortion rights remain the nation’s predominant political issue.
Doctor suing FDA recruited to scientific advisory board to ‘repurpose’ abortion pill
Dr. George Delgado is joining the scientific advisory board of Res Nova Biologics, Inc., which is developing a breast cancer treatment using mifepristone.
A men’s movement takes reins in a nationwide quest to end abortion
A male-dominated network of militants, academics, attorneys, judges and activists lead the drive to restrict and remove reproductive rights.
Study cited by Texas judge in abortion-pill case under investigation
The authors of the study exaggerated their findings and visually misrepresented them in ways that are “grossly misleading," one expert says.
After Dobbs, abortion access in U.S. is harder, comes later and with a higher risk
State laws restricting abortion have caused more women to travel to seek the procedure, overwhelming clinics and leading to astronomical patient costs and major care delays.
Appeals court judges embrace anti-abortion speculation
The judges who heard arguments in the abortion pill case Wednesday appeared to be persuaded by evidence that consists largely of anecdotes, speculation, and cherry-picked studies brought by a handful of anti-abortion medical groups and doctors.
What abortion foes have been up to since Dobbs ruling leaked
Anti-abortion activists have flooded state legislatures and city governments with proposals to criminalize pregnancy termination or to add burdensome regulations, and are defending many of them in state and federal court.
After SCOTUS ruling, disappointed abortion foes vow to keep attacking abortion pill
Just this week, anti-abortion activists once again petitioned the FDA to revoke the approval of mifepristone, but this time on (disputed) environmental grounds.